• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Infect Dis Rep . Circulation of SARS-CoV-2 and Co-Infection with Plasmodium falciparum in Equatorial Guinea

tetano

Editor, Senior Moderator
Infect Dis Rep


. 2025 Sep 10;17(5):111.
doi: 10.3390/idr17050111. Circulation of SARS-CoV-2 and Co-Infection with Plasmodium falciparum in Equatorial Guinea

Diana López-Farfán[SUP] 1 [/SUP], Policarpo Ncogo[SUP] 2 3 [/SUP], Consuelo Oki[SUP] 4 [/SUP], Matilde Riloha[SUP] 4 [/SUP], Valero Ondo[SUP] 4 [/SUP], Pablo Cano-Jiménez[SUP] 5 [/SUP], Francisco José Martínez-Martínez[SUP] 5 [/SUP], Irene Molina-de la Fuente[SUP] 2 6 [/SUP], Iñaki Comas[SUP] 5 7 [/SUP], Nerea Irigoyen[SUP] 8 [/SUP], Pedro Berzosa[SUP] 3 6 [/SUP], Agustín Benito Llanes[SUP] 6 [/SUP], Elena Gómez-Díaz[SUP] 1 [/SUP]



Affiliations
Abstract

Background/Objectives: The impact of COVID-19 in Africa has been controversial. Data from African countries are heterogeneous and generally scarce. Many regions are also highly endemic for other infectious diseases like malaria, and it has been suggested that the low incidence and mortality of COVID-19 in malaria-endemic regions could have been related to cross-immunity between malaria and SARS-CoV-2. The aim of this study was to determine the prevalence of SARS-CoV-2 and circulating variants as well as the frequency of co-infections with malaria in Equatorial Guinea. Methods: We conducted antigen tests for SARS-CoV-2 and microscopy malaria examinations in 1556 volunteer participants at six health centres in Bioko and Bata from June to October 2021 and performed SARS-CoV-2 whole-genome sequencing on positive samples to determine the diversity and origin of circulating variants. Results: We report 3.03% of SARS-CoV-2 and 22.25% of malaria prevalence over the sampling period; SARS-CoV-2 cases were found at a similar frequency in all age groups, whereas malaria was most frequent in children and teenagers. Six cases of malaria and SARS-CoV-2 co-infection were found, representing 0.37% prevalence. Genome sequences of 43 SARS-CoV-2 isolates are reported, most of which belong to the lineage Delta and, according to pandemic-scale phylogenies, were introduced from Europe on multiple occasions. Conclusions: This study is relevant in providing first-time estimates of the real prevalence of SARS-CoV-2 in this malaria-endemic country, with the identification of circulating variants, their origin, and co-occurrence with malaria. These data regarding the impact of the pandemic and co-infection with endemic diseases are relevant in future pandemics preparedness.

Keywords: Africa; COVID-19; co-infection; coronavirus; genomic surveillance; malaria.

 
Back
Top Bottom